Skip to content
healthcare.dev

Severe Cold Head Congestion

NDC 68998-175, ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, tablet, coated, from Marc Glassman, Inc..

Product NDC
68998-175
Status
Listed
Labeler
Marc Glassman, Inc.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
part341
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68998-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN325 mg/1
  • GUAIFENESIN200 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
68998-175-02689980175022 BLISTER PACK in 1 CARTON (68998-175-02) / 12 TABLET, COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68998-175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68998-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68998-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.